Clinical Trials Us
- All
- News
- Videos
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
US Woman With Stage 4, 'Incurable' Colon Cancer Saved By Breakthrough Treatment
Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of which seemingly worked.
-
Study Finds Severe Covid Response Could Help Shrink Tumors
A groundbreaking study suggests severe COVID infections may generate special immune cells capable of shrinking advanced cancers in mice, opening doors to innovative cancer treatments.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
US Woman With Stage 4, 'Incurable' Colon Cancer Saved By Breakthrough Treatment
Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of which seemingly worked.
-
Study Finds Severe Covid Response Could Help Shrink Tumors
A groundbreaking study suggests severe COVID infections may generate special immune cells capable of shrinking advanced cancers in mice, opening doors to innovative cancer treatments.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
